Gaurav Seth appointed as CEO of 5paisa Capital Limited, effective January 14, 2025
Dabur India Q3 Results FY2023, PAT at Rs. 476.65 crores

On 2nd February, Dabur India announced its results for the third quarter of FY2023.
Key Highlights:
- Consolidated Revenue for the third quarter of 2022-23 stood at Rs. 3,043.17 crores.
- The net profit was reported at Rs. 476.65 crores with a 3-year CAGR at 6.1%.
Business Highlights:
- Dabur's Home care business ended the quarter with an 18.2% growth
- The Ayurvedic OTC business grew by 76.8% in Q3, while the Digestives category reported an 11.2% growth.
- Dabur's Food & Beverages business reported a 6.4% growth during the quarter, while the Toothpaste business, led by steady demand for the flagship Dabur Red paste, ended the quarter with a 32% growth.
- Dabur posted market share gains across the portfolio, led by a 250bps improvement in Juices & Nectars market share
- Dabur also reported a 70bps market share gain in Hair Oils to touch the highest-ever 16.2%.
- Dabur's share in the Chyawanprash category improved by 30bps.
- Dabur also reported a 40bps increase in Shampoo market share.
- Dabur's international Business reported a growth of 14% in Constant Currency terms, with a 3-Year CAGR of 14.1%. The Turkey business grew by 97%, while the Egypt business was up by 35%. The Sub-Saharan Africa business reported a growth of 17%, while the SAARC market grew by 8%
Commenting on the results, Dabur India Ltd Chief Executive Officer Mr. Mohit Malhotra said:
"We have delivered steady results in what continues to be a difficult cost and operating environment. We continued to adjust prices responsibly to reflect inflation, Our India business reported a growth of 3.3% with a 3-year CAGR of 9s% and steady market share gains across the portfolio, despite most operating categories reporting a decline."
- Flat ₹20 Brokerage
- Next-gen Trading
- Advance Charting
- Actionable Ideas
Trending on 5paisa
02
5paisa Research Team
03
5paisa Research Team
04
5paisa Research Team
Corporate Actions Related Articles
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.